Clinical-stage biopharmaceutical company Omeros Corporation said that it has discovered the proteins that activate the alternative pathway of the complement system as part of the company's mannan-binding lectin associated serine protease-2 ...
Tags: complement system, protease-2(MASP-2)program, pro-inflammatory protein